drugset / Trial / NCT00259285

Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer

NCT00259285 ↗

Phase 2 Terminated 10 enrolled Eli Lilly and Company
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To determine the response to this regimen for therapy prior surgery in patients with locally advanced disease or metastatic disease.

Timeline

Start
2005-11
Primary completion
2007-12
Completion
2007-12

Outcome

Outcome not reported

Stopped (Enrollment): “Trial was stopped early due to low enrollment.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 75 mg/m2 Intravenous
Subject Pemetrexed Small molecule 500 mg/m2 Intravenous